C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2006
10/24/2006	US7126042 Recombinant oleosins from cacao and their use as flavoring or emulsifying agents
10/24/2006	US7126041 High efficiency gene targeting in plants
10/24/2006	US7126039 Animal tissue with carbohydrate antigens compatible for human transplantation
10/24/2006	US7125979 Upstream control elements of the proopiomelanocortin gene and their use
10/24/2006	US7125974 Viral sequences
10/24/2006	US7125973 Cell surface display of proteins by recombinant host cells
10/24/2006	US7125971 Full-length genomic RNA of papaya leaf-distortion mosaic virus
10/24/2006	US7125970 Host cells; drug screening; antigrowth agents
10/24/2006	US7125964 Using magnetic beads conjugated with major histocompatability complex peptides to purify and expand in vitro tumor- and virus-specific killer lymphocytes for use in cell therapy, tissue targeted therapy and engineering
10/24/2006	US7125719 Polypeptides; transgenic plant; stress tolerance
10/24/2006	US7125717 Metabolically activated recombinant viral vectors and methods for their preparation and use
10/24/2006	US7125716 Culturable mitochondrial cells with no nucleus, showing mitochondrial activity
10/24/2006	US7125715 Nucleic acid encoding a polypeptide promoting type II collagen formation and aggrecan production
10/24/2006	US7125714 Progenitor cell materials and methods
10/24/2006	US7125713 Human mullerian duct-derived epithelial cells and methods of isolation and uses thereof
10/24/2006	US7125712 DNA segment from a BIV genome; a packaging sequence to package RNA into virions; a first promoter operably linked to the DNA segment; d) a transgene operably linked to a second promoter and deletion of vpw, vpy and tat from the construct
10/24/2006	US7125709 May be a multiwell plate or slide coated with a metal salt transfection agent such as CaCl2, used for determining whether biomolecules can enter eukaryotic cells,
10/24/2006	US7125706 Method for the production and purification of adenoviral vectors
10/24/2006	US7125705 Expression vector for use as tool in genetic engineering and gene therapy
10/24/2006	US7125699 for treating solid tumours, macular degeneration, corneal rejection, psoriasis, rheumatoid arthritis and chronic ulceration, and diseases involving vascular insufficiency, including stroke and following heart attack
10/24/2006	US7125687 Presenilin enhancers assays
10/24/2006	US7125686 Proteins and methods for producing the proteins
10/24/2006	US7125684 Treating fertility disorders; maternal-antigen-that-embryos-require (MATER)
10/24/2006	US7125676 Modified human sodium channel type 1 alpha subunit (SCN1A) nucleic acid that encodes an SCN1A voltage-gated sodium channel polypeptide that regulates Na+ ion membrane permeation; identifying a sodium channel modulator
10/24/2006	US7125675 Method for inhibiting tumor invasion or spreading in a subject
10/24/2006	US7125670 Comprises activated CD4 T-cells (ACT-4-L) ligand polypeptide for detection of immunomodulators; autoimmune diseases; drug screening; immunosuppressants; viricides
10/24/2006	US7125663 Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
10/24/2006	US7125658 Small protein that interacts with a ribonucleotide reductase subunit and uses thereof
10/24/2006	US7125557 Isolated haemocyanin polypeptide having a specific amino acid sequence recombinantly expressed in a host cell, wherein the glycosylation pattern is different from naturally occurring KLH from Megathura crenulata; may be bonded to a virus, bacteria, DNA, carbohydrate, peptide or glycoprotein
10/24/2006	US7125551 Compound for use inthe diagnosis and treatment of cancer, viral, asthmatic, autoimmune, organ transplant rejection and infections
10/24/2006	US7125550 Play a role in capacitation of sperm and the fertilization of the ovum and make ideal targets for the design of contraceptive agents.
10/24/2006	CA2121545C Method for transforming monocotyledons
10/19/2006	WO2006110806A2 Multipotent adult stem cells
10/19/2006	WO2006110760A2 Compositions and methods for the diagnosis and treatment of tumor
10/19/2006	WO2006110582A1 Compositions and methods for the treatment of burns and sepsis
10/19/2006	WO2006109781A1 Process for production of glycoprotein composition
10/19/2006	WO2006109698A1 Composition comprising genetically engineered erythropoietin
10/19/2006	WO2006109696A1 Composition comprising genetically engineered follicle-stimulating hormone
10/19/2006	WO2006109695A1 Composition comprising genetically engineered haptoglobin
10/19/2006	WO2006109619A1 5-fluorouracil-resistant bacteria and method for production thereof
10/19/2006	WO2006109578A1 Altered pyrroloquinoline-quinone-dependent glucose dehydrogenase and method of improving substrate specificity of pyrroloquinoline-quinone-dependent glucose dehydrogenase
10/19/2006	WO2006109533A1 Method for production of antibody directed against cell membrane surface antigen epitope and assaying method
10/19/2006	WO2006109424A1 Dnas encoding protein having function of forming and regulating cellulosic fiber cell wall in tree trunk and promoter dnas of the same
10/19/2006	WO2006109420A1 Method of examining plant qualities and species
10/19/2006	WO2006109367A1 Cell release method, cell release solution, cell culture method, cell culture medium, cell solution, cell solution preparation, cell colonization method and cell colonization solution
10/19/2006	WO2006109286A1 Filamentous hemagglutinin for the prevention of the development of neutralising antibodies to a biologic agent
10/19/2006	WO2006109285A1 Methods and compounds for the treatment of autoimmune diseases and chronic inflammatory conditions
10/19/2006	WO2006109284A1 Use of filamentous hemagglutinin for the treatment of cognitive dysfunction and neurodegenerative disorders
10/19/2006	WO2006109137A1 Tissue regeneration by endocultivation
10/19/2006	WO2006108882A1 In vitro production of a cell population using feeder cells
10/19/2006	WO2006108846A1 Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
10/19/2006	WO2006108574A1 Method for the delivery of exogenous antigens into the mhc class i presentation pathway of cells
10/19/2006	WO2006108455A1 Serum-free cell culture medium for mammalian cells
10/19/2006	WO2006108361A1 Method of inducing embryonic stem cells into pancreatic cells
10/19/2006	WO2006108284A1 Methods for the derivation of germ cells from skin stem cells
10/19/2006	WO2006108234A1 Modified animal lacking functional pyy gene, monoclonal antibodies that bind pyy isoforms and uses therefor
10/19/2006	WO2006108229A1 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
10/19/2006	WO2006078782A3 Compositions containing agm cells and methods of use thereof
10/19/2006	WO2006077404A3 Cell adhesion by modified cadherin molecules
10/19/2006	WO2006072803A3 Antibody
10/19/2006	WO2006065975B1 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor
10/19/2006	WO2006065126A3 Terpene hydroxylation
10/19/2006	WO2006060649A3 Therapeutic antisense oligonucleotide composition for the treatment of inflammatory bowel disease
10/19/2006	WO2006053201A3 Treatment of cancer by simultaneous inhibition of b-raf and restoration or mimicry of p16 ink4a activity
10/19/2006	WO2006051405A3 Methods and means related to cancer stem cells
10/19/2006	WO2006041910A3 Stem cells derived from uniparental embryos and methods of use thereof
10/19/2006	WO2006024291A3 Root-specific and xylem parenchyma-specific promoter
10/19/2006	WO2006009814A3 Products and methods related to mono-methyl branched-chain fatty acids
10/19/2006	WO2005104790A3 Treatment of muscular dystrophy with mobilized peripheral blood pluripotent cells
10/19/2006	WO2005092924A8 Rab9a, rab11a, and modulators thereof related to infectious disease
10/19/2006	WO2005092058A3 Methods for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses
10/19/2006	WO2004084810A3 Novel imidazoline receptor homologs
10/19/2006	WO2004020605A3 Circular nucleic acid vectors, and methods for making and using the same
10/19/2006	WO2003027637A3 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
10/19/2006	US20060236435 Chimeric plant promoters and plants containing the same
10/19/2006	US20060236434 Methods and compositions for tobacco plants with reduced nicotine
10/19/2006	US20060236432 Plant regulatory sequences for use in tissue specific expression of exogenous genes
10/19/2006	US20060236431 Gene encoding protein involved in cytokinin synthesis
10/19/2006	US20060236430 Methods and compositions for producing male sterile plants
10/19/2006	US20060236428 Manipulation of cellulose and/or beta-1,4-glucan
10/19/2006	US20060236426 Nucleic acid molecules encoding starch degrading enzymes
10/19/2006	US20060236424 Methods and compositions for designing nucleic acid molecules for polypeptide expression in plants using plant virus codon-bias
10/19/2006	US20060236423 Insecticidal plant cyclotide with activity against homopteran insects
10/19/2006	US20060236421 Secondary metabolite production via manipulation of genome methylation
10/19/2006	US20060236418 Genetically modified non-human mammals and cells
10/19/2006	US20060236411 Antagonists il-15
10/19/2006	US20060236410 Protein specific for cardiac and skeletal muscle
10/19/2006	US20060235207 Antibodies against lesion tissue
10/19/2006	US20060235201 Enduring T cell response
10/19/2006	US20060234965 Novel full-length genomic rna of Japanese encephalitis virus, infectious jev cdna therefrom, and use thereof
10/19/2006	US20060234941 Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis
10/19/2006	US20060234924 A kit for screening a compound or its salt that promotes or inhibits the activity of the proteins; drug screening for hyperlipemia, arteriosclerosis, genital, digestive, respiratory diseases, renal, pancreatic, central nerve, respiratory, inflammatory, rheumatoid diseases and diabetic neurosis
10/19/2006	US20060234379 Cell separation method using hydrophobic solid supports
10/19/2006	US20060234378 Molecular switch regulating neurogenesis
10/19/2006	US20060234377 Cell sheets for ectocornea formation, method of producing the same and method of using the same
10/19/2006	US20060234376 Repair and regeneration of ocular tissue using postpartum-derived cells
10/19/2006	US20060234375 Use of human stem cells and/or factors they produce to promote adult mammalian cardiac repair through cardiomyocyte cell division
10/19/2006	US20060234374 Malignant Cells and Method for Selecting the Same
10/19/2006	US20060234373 Treatment for diabetes
10/19/2006	US20060234369 Implantable biosensor

1 ... 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 ... 1827